Akoustis Technologies (AKTS)

Akoustis Technologies (AKTS) Income Statement


Akoustis Technologies Income Statement

Last quarter (Q4 2023), Akoustis Technologies's total revenue was $8.33M, an increase of 60.15% from the same quarter last year. In Q4, Akoustis Technologies's net income was $-17.77M. See Akoustis Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ 27.12M$ 27.12M$ 15.35M$ 6.62M$ 1.79M$ 1.44M
Cost of Revenue
$ 10.23M$ 30.24M$ 19.49M$ 10.65M$ 2.41M$ 1.01M
Gross Profit
$ -3.12M$ -3.12M$ 15.35M$ -4.03M$ -624.00K$ 430.00K
Operating Expense
$ 3.65M$ 62.95M$ 56.42M$ 37.36M$ 31.41M$ 28.00M
Operating Income
$ -16.79M$ -66.07M$ -41.07M$ -41.39M$ -32.04M$ -27.57M
Net Non Operating Interest Income Expense
$ -1.58M$ -2.32M$ -77.00K$ -5.13M$ -4.57M$ -2.89M
Other Income Expense
$ -3.74M$ -2.39M$ 19.88M$ 2.37M$ 471.00K$ 1.21M
Pretax Income
$ -66.00M$ -66.00M$ -61.03M$ -44.16M$ -36.14M$ -29.25M
Tax Provision
$ -2.45M$ -2.45M$ -1.83M---
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -14.28M$ -63.56M$ -59.03M$ -44.16M$ -36.14M$ -29.25M
Basic EPS
$ -1.00$ -1.00$ -1.09$ -1.02$ -1.07$ -1.06
Diluted EPS
$ -0.87$ -1.00$ -1.09$ -1.02$ -1.07$ -1.06
Basic Average Shares
$ 254.49M$ 63.62M$ 54.02M$ 43.43M$ 33.70M$ 27.51M
Diluted Average Shares
$ 196.90M$ 63.62M$ 54.02M$ 43.43M$ 33.70M$ 27.51M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 132.98M$ 123.43M$ 75.91M$ 48.01M$ 33.83M$ 29.01M
Net Income From Continuing And Discontinued Operation
$ -63.56M$ -63.56M$ -59.03M$ -44.16M$ -36.14M$ -29.25M
Normalized Income
$ -31.89M$ -75.55M-$ -46.52M$ -35.98M$ -29.40M
Interest Expense
$ -62.50M$ -63.68M$ -60.95M$ -41.39M$ -32.04M$ -27.57M
$ -50.43M$ -51.47M$ -52.80M$ -36.51M$ -28.85M$ -25.07M
Currency in USD

Akoustis Technologies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis